NSW government expands Westmead biomedical research facility to commercial scale.

The NSW government is expanding a biomedical research facility in Sydney's Westmead to a commercial scale, aiming to establish the city as a global research hub for life-saving therapies and vaccines. The facility uses viral vector technology to treat cancer, genetic diseases, and infections, and has received a $134.5 million investment. The expansion will provide commercial-scale viral vector manufacturing, meeting local demand and positioning the state as a leader in the field of gene therapies, cell therapies, and vaccines.

February 25, 2024
6 Articles

Further Reading